Zydus Cadila gets USFDA's approval for Butalbital, Acetaminophen, Caffeine Tablets

18 Jul 2020 Evaluate
Zydus Cadila has received final approval from the USFDA to market Butalbital, Acetaminophen and Caffeine Tablets (US RLD: Butalbital, Acetaminophen and Caffeine Tablets) in the strengths 50mg/325mg/40 mg. This combination of medication is used to treat symptom complex of tension (or muscle contraction) headache. The drug will be manufactured at Nesher Pharma’s manufacturing facility at St. Louis, USA.

The group now has 294 approvals and has so far filed over 390 ANDAs since the commencement of the filing process in FY 2003-04.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

953.85 2.90 (0.30%)
26-Apr-2024 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1514.00
Dr. Reddys Lab 6215.00
Cipla 1404.25
Zydus Lifesciences 953.85
Lupin 1607.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.